Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
09/2003
09/25/2003WO2003078361A1 Controlling chemical reactions by spectral chemistry and spectral conditioning
09/25/2003WO2003077951A1 Percutaneous absorption promoters and compositions for treating athlete’s foot
09/25/2003WO2003077947A1 Methods of modulating cd200 receptors
09/25/2003WO2003077944A1 Improvements in vaccination
09/25/2003WO2003077942A2 Virus-like particles of human papillomavirus
09/25/2003WO2003077938A1 Use of polypeptides of human origin for the treatment of microbial infectious diseases
09/25/2003WO2003077937A1 Pharmaceutical compositions comprising mannose binding lectin
09/25/2003WO2003077922A1 Composition in an aqueous gel state, method for the production and use thereof in the production of a medicament, in particular an antiherpetic medicament
09/25/2003WO2003077921A1 Azinylaminoazoles as inhibitors of protein kinases
09/25/2003WO2003077919A1 Fluorinated 4-azasteroid derivatives as androgen receptor modulators
09/25/2003WO2003077915A1 Use of rapamycin for inhibiting of cell death
09/25/2003WO2003077913A1 Peptide deformylase inhibitors
09/25/2003WO2003077904A1 Biological activity-promoting compositions containing soybean germ-origin isoflavone aglycon
09/25/2003WO2003077882A2 Preparation of sterile stabilized nanodispersions
09/25/2003WO2003077881A2 Method for production of phytoalexins
09/25/2003WO2003077862A2 Potent, simplified derivatives of immunosuppressive agents
09/25/2003WO2003077859A2 Method of inducing an enhanced immune response against hiv
09/25/2003WO2003077857A2 N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7- carboxamides useful as hiv integrase inhibitors
09/25/2003WO2003077850A2 N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7- carboxamides useful as hiv integrase inhibitors
09/25/2003WO2003077840A2 Method of modulating inflammatory response
09/25/2003WO2003077834A2 Central airway administration for systemic delivery of therapeutics
09/25/2003WO2003077832A2 Dexanabinol and dexanabinol analogs regulate inflammation related genes
09/25/2003WO2003077830A2 9-dexo-9a-aza-9a-methyl-9a-homoerythromycin a derivatives
09/25/2003WO2003077829A2 Process for preparation of a pharmaceutical composition containing acid labile compounds
09/25/2003WO2003077828A2 Novel florfenicol-type antibiotics
09/25/2003WO2003077656A1 4-aminopyrimidines and their use for the antimicrobial treatment of surfaces
09/25/2003WO2003077653A1 Autoinducer compounds
09/25/2003WO2003068171A3 Method and composition for treatment of inflammation and aids-associated neurological disorders
09/25/2003WO2003042411A3 Use of mutations of mec-1 and its related genes in the identification of compounds for treatment of disease
09/25/2003WO2003039472A3 Intraorally disintegrating valdecoxib compositions prepared by fluid bed granulation process
09/25/2003WO2003020219A3 Aerosolized decongestants for the treatment of sinusitis
09/25/2003WO2003013530A3 Salts of substituted 1, 2, 3, 4-tetrahydroquinoline-2-carboxylic acid derivatives as nmda antagonists
09/25/2003WO2003012078A3 Dendritic cells and the uses thereof in screening cellular targets and potential drugs
09/25/2003WO2003011855A3 Pyrazole-derived kinase inhibitors and uses thereof
09/25/2003WO2003011331A3 Materials and methods relating to improved vaccination strategies
09/25/2003WO2003004627A3 Novel human hepatoma lines, methods for obtaining same and uses thereof
09/25/2003WO2003000709A3 Sialic acid derivatives for use as siglec inhibitors
09/25/2003WO2002097081A3 Method to generate non virulent microorganisms from pathogenic ones trough permanent genetic modification of their biological membrane for vaccine production
09/25/2003WO2002094287A3 Identifying parasitic fungi of the organism, and treatment thereof
09/25/2003WO2002092826A3 Composition and method for treating cancer using herpes virus
09/25/2003WO2002080911A3 Use of substituted imidazo[1,2-a]-pyridine-3-yl-amide and imidazo[1,2-a]-pyridine-3-yl-amine compounds as medicaments for the treatment of neurodegenerative diseases
09/25/2003WO2002064634A3 Human monoclonal antibodies to fc alpha receptor (cd89)
09/25/2003WO2002064612A9 Human g-protein chemokine receptor (ccr5) hdgnr10
09/25/2003WO2002063004A3 G-protein coupled receptors
09/25/2003WO2002062368A3 Method of inducing a ctl response
09/25/2003WO2002030884A3 Sulfide and disulfide compounds and compositions for cholesterol management and related uses
09/25/2003WO2002030882A3 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
09/25/2003WO2002022115A3 Methods and compositions for treating nail fungus
09/25/2003WO2002014489A9 Leucine-rich repeat-containing g-protein coupled receptor-8 molecules and uses thereof
09/25/2003US20030181847 For topical treatment of nail diseases (onychomycosis) after forming aperture in infected nail with laser beam; fungicides (terbinafine)
09/25/2003US20030181720 Chemical intermediate for making fungicides; debromination, hydroxylation, formation/c-c/
09/25/2003US20030181719 Novel heterocyclic antibacterial compounds
09/25/2003US20030181714 Oligosaccharide chain, which contianing a terminal NeuNAc alpha 6 linked to a linear or branched polylcatosamine type structure containing at least 3 lactosamine; a linear or branched structure with two lactosamine and one lactose
09/25/2003US20030181689 Percarboxylated polysaccharides, and a process for their preparation
09/25/2003US20030181519 Substituted phenyl naphthalenes as estrogenic agents
09/25/2003US20030181514 Therapeutic compounds and methods
09/25/2003US20030181507 Use of 3-substituted oxindole derivatives as kcnq potassium channel modulators
09/25/2003US20030181505 Novel antifungal molecule 2-(3,4-dimethyl-2,5-dihydro-1h-pyrrol-2-yl)-1-methylethyl pentanoate
09/25/2003US20030181502 Methods of treating sepsis
09/25/2003US20030181497 Heterocyclic acridone inhibitors of IMPDH enzyme
09/25/2003US20030181490 For therapy and prophylaxis of acquired immune deficiency syndrome (AIDS), or ARC
09/25/2003US20030181487 Salts of benzimidazole compound and use thereof
09/25/2003US20030181481 Therapeutic drugs for treating central nervous system disorders
09/25/2003US20030181477 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor
09/25/2003US20030181476 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use thereof
09/25/2003US20030181470 Heterocyclic compounds and uses thereof as D-alanyl-D-alanine ligase inhibitors
09/25/2003US20030181467 Multiple acting anti-angiogenic and cytotoxic compounds and methods for using the same
09/25/2003US20030181452 Inotropic agents such as (S)-N-tert-butyloxycarbonyl-N-methyl-tyrosyl)-4-(4-nitrophenyl)-piperazine, used for preventing and/or prophylaxis of diseases associated with adenosine 5'-triphosphate
09/25/2003US20030181443 Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof
09/25/2003US20030181441 Tumor necrosis factor-alpha converting enzyme antagonists, such as (2S,3S)-4-(4-(3,5-difluro-benzyloxy)-benzenesulfonyl) -2-methyl-thiomorpholine-3-carboxylic acid hydroxyamide, used as antiarthritic or anticarcinogenic agents
09/25/2003US20030181439 Use of paullone derivatives for making medicines
09/25/2003US20030181436 Administering iodiscorbate compound containing strontium, iodine, ascorbic acid, and a diamagnetic ion, either zinc, bismuth, or potassium
09/25/2003US20030181425 Lysergol enhances transport of antibiotics across the intestinal gut and cell membrane for better efficacy on the target site
09/25/2003US20030181416 Antimicrobial charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and method of use thereof
09/25/2003US20030181398 Injecting penicillins, cephalosporins, tetracyclines, erythromycins, tylosins, quinolone and other antibiotics, to skins of animals such as cattle, swine or sheep, for prophylaxis of respiratory system disorders
09/25/2003US20030181394 Carbobydrates such as alpha-D-galactopyranosyl-1,2-glycerol and/or isomers, obtained by solvent extraction from algae, for use as viricides or anticarcinogenic agents
09/25/2003US20030181382 Protein fragments which have antiviral activity, and particularly relates to HIV peptides derived from the HIV transmembrane glycoprotein (gp41) which inhibit HIV-induced cell-cell fusion. This invention further relates to methods
09/25/2003US20030181363 Compounds or pharmaceutically acceptable salt thereof, useful as inhibitors of the HCV NS3 protease.
09/25/2003US20030181359 Tripeptide prodrug compounds
09/25/2003US20030180953 Gene disruption methodologies for drug target discovery
09/25/2003US20030180947 Circadian control of stem/progenitor cell self-renewal and differentiation and of clock controlled gene expression
09/25/2003US20030180934 Plasminogen-like polynucleotides, polypeptides, and antibodies
09/25/2003US20030180931 Cellubrevin homologs
09/25/2003US20030180893 Biotransformation of biologically active compounds made of various classes of chemical substance by means of laccase and manganese peroxidase enzymes
09/25/2003US20030180877 Gene therapy; drug screening
09/25/2003US20030180818 Isolated nucleic acid molecules encoding human peptidoglycan recognition protein-related proteins, referred to PGRP-K (keratinocytes), PGRP-W (wound healing) and PGRP-C (chondrosarcoma)
09/25/2003US20030180785 Polynucleotide molecules encoding Neospora proteins
09/25/2003US20030180778 UDP-N-acetylglucosamine: galactose-beta1,3-N-acetylgalactosamine-alpha-R/ (GlcNAc to GalNAc) beta1,6-N-acetylglucosaminyltransferase, C2GnT3
09/25/2003US20030180755 Pharmaceutical compositions in particulate form
09/25/2003US20030180734 Peptide nucleic acids
09/25/2003US20030180386 Aqueous metal bicarbonate solution and method of use
09/25/2003US20030180366 Bioadhesive drug delivery system
09/25/2003US20030180357 Core with coating; water soluble dye in matrix as core; gellan gum coatings; easier detection of tablet
09/25/2003US20030180349 Administering before or after onset of disease
09/25/2003US20030180328 Forming vaccines; analyzing hemagglutinin, calibration
09/25/2003US20030180327 Veterinary medicine; induce immunology response
09/25/2003US20030180326 Methods and compositions for impairing multiplication of HIV-1
09/25/2003US20030180322 Genome segments; detection of phenotype
09/25/2003US20030180320 Dna vaccines; genetic engineering; eukaroytic gene expression; screening libraries
09/25/2003US20030180317 Diagnosis ear infections in children
1 ... 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 ... 1798